Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Pemirolast"'
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 15, Pp 2099-2107 (2021)
Ting Shen, Zijian Yang Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaCorrespondence: Zijian YangDepartment of Ophthalmology, Ruijin Hospital Affiliated Medi
Externí odkaz:
https://doaj.org/article/42015690d53444aea9916679cb6de1ff
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ting Shen, Zijian Yang
Publikováno v:
Drug Design, Development and Therapy
Ting Shen, Zijian Yang Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, Shanghai, People’s Republic of ChinaCorrespondence: Zijian YangDepartment of Ophthalmology, Ruijin Hospital Affiliated Medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aee976966354603e337e9fae0d5572f6
https://doi.org/10.2147/dddt.s308448
https://doi.org/10.2147/dddt.s308448
Publikováno v:
Open Medicine, Vol 8, Iss 6, Pp 766-775 (2013)
Externí odkaz:
https://doaj.org/article/a1b7da811087482585744156e05f4eb4
Autor:
Abhrajit Bag, Arijit Bag
Publikováno v:
Acta Scientific Pharmaceutical Sciences. 4:77-81
To find an immediately applicable drug for the treatment of COVID-19 positive patients, a plausible life cycle of this virus is proposed from the analysis of a few case reports. Based on this proposal and symptomatic similarities, a few common drug-m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b12ee825d834296a8a94b9eaf2f8e090
https://doi.org/10.31080/asps.2020.04.0620
https://doi.org/10.31080/asps.2020.04.0620
Autor:
Li Hang
Publikováno v:
Guoji Yanke Zazhi, Vol 13, Iss 12, Pp 2468-2470 (2013)
AIM: To investigate the clinical effectiveness of houttuynia cordata eye drops combined with pemirolast potassium eye drops on the patients with allergic conjunctivitis. METHODS: Totally, 63 patients with allergic conjunctivitis were randomly divided
Externí odkaz:
https://doaj.org/article/d085438633b2457e92111bdc1d7968b3
Publikováno v:
Open Medicine, Vol 8, Iss 6, Pp 766-775 (2013)
Cyclophosphamide (CP) treatment is associated with the risk of haemorrhagic cystitis (HC). Moreover, CP-induced HC is complicated by autonomic nervous system (ANS) dysfunction. Pemirolast is thought to be a mast cell stabiliser that inhibits the rele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e7d7d99ffaf5eec9a64c18f5abb5f2e
https://doaj.org/article/a1b7da811087482585744156e05f4eb4
https://doaj.org/article/a1b7da811087482585744156e05f4eb4
Autor:
Dina Wahba Hassan, Maissa Salem Yaaqob, Nadia F. Youssef, Soheir Abd El-Fatah Weshahy, Marianne Nebsen Morcos
Publikováno v:
RSC Advances. 5:74366-74373
The stability of the anti-asthmatic drug pemirolast potassium was investigated under different stress conditions, including hydrolysis (acid and alkali), heat, light and oxidation as recommended by the ICH guidelines. The degradation process was foun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f81919400d5ab78289a49725414b8217
https://doi.org/10.1039/c5ra12679g
https://doi.org/10.1039/c5ra12679g
Publikováno v:
Arzneimittelforschung. 58:18-23
It is still difficult to manage chronic glomerulonephritis with corticosteroids because of safety concerns, especially for patients with mild symptoms and infants. Therefore, an alternative approach is greatly required. Pemirolast potassium (CAS 1002
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be345249d704d13a9fa96a5a22facf22
https://doi.org/10.1055/s-0031-1296461
https://doi.org/10.1055/s-0031-1296461
Autor:
Kentaro Kurobe, Naohiro Matsushita, Takahisa Yano, Yoko Tatsushima, Nobuaki Egashira, Takehiro Kawashiri, Ryozo Oishi
Publikováno v:
European Journal of Pharmacology. 661:57-62
Emesis is the most feared side effect in patients who are undergoing cancer chemotherapy. In particular, cisplatin causes severe acute and delayed emesis. Although early vomiting is well controlled by 5-hydroxytryptamine 3 (5-HT(3)) receptor antagoni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e11a9af7ddc4d3bbd6118eb4b5928fbc
https://doi.org/10.1016/j.ejphar.2011.04.026
https://doi.org/10.1016/j.ejphar.2011.04.026